Table 5.
Univariable Cox regression for log2(NLR)
Outcome | Number of events | Estimated hazard ratio (95% CI) | p value |
---|---|---|---|
Overall CTR-CVT | 50 | 1.443 (1.082–1.925) | 0.013* |
CTRCD | 17 | 1.448 (0.799–2.626) | 0.222 |
Myocarditis | 4 | 5.556 (2.077–14.861) | < 0.001* |
Vascular toxicity | 17 | 1.314 (0.794–2.175) | 0.288 |
New onset of arterial hypertension | 3 | 1.994 (0.682–5.826) | 0.207 |
Arrhythmia or QTc prolongation | 22 | 1.741 (1.161–2.610) | 0.007* |
NLR neutrophil-to-lymphocyte ratio; CI confidence interval; CTR-CVT cancer therapy-related cardiovascular toxicity; CTRCD cancer therapy-related cardiovascular dysfunction
*Statistically significant association between NLR and outcome